LGND
Ligand Pharmaceuticals Inc.
$201.63
-1.34%
-2.73
Notify me if price changes either direction
Buy LGND stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
4.0B
Enterprise value
3.7B
Trailing PE
88.612335
Forward PE
23.901724
PEG Ratio
-0.054167414811912
Enterprise to EBITDA
59.42
Enterprise to revenue
14.908
Price to book MRQ
4.16115
Price to sales TTM
15.758192
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
251.2M
EBITDA
11.4M
Diluted EPS TTM
2.27
Total Cash (MRQ)
664.5M
Current ratio (MRQ)
24.687
Operating Cash Flow (TTM)
31.9M
LGND trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
January 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
